More specifically, BRCA1 and BRCA2 mutations have been linked to an increased risk of developing ovarian cancer by 50% and 20%, respectively [40,42,43,44,45,46,47,48,49,50,51]. This evidence concerns the gene BRCA2 and ovarian carcinoma.